DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Treatment Action Group
Treatment Action Group
2016 Research in Action Awards
2014 Annual Report Progress in the Fight for Better Treatment, a Vaccine, and a Cure for Aids
RIGHT to SCIENCE Tagline Vol
The Future of Biomedical Hiv Prevention Trials: Researcher Viewpoints and Community Survey
What's in the Pipeline: New HIV Drugs, Vaccines, Microbicides, HCV And
TAG Update 2006
HCV Diagnostics PIPELINE REPORT 2020
Hepatitis C and COVID-19 Global Concerns: Sustained Financing and Expanded Access to Testing and Pangenotypic Treatments Needed to Recover the Path to Elimination
June 7, 2021 To: Dr. Philippe Duneton
HCV Diagnostics PIPELINE REPORT 2019
Hepatitis C and COVID-19 Global Concerns: Sustained Financing and Expanded Access to Testing and Pangenotypic Treatments Needed to Recover the Path to Elimination
2019 TAG Annual Report
A Critical Review of the Research and Treatment of Hepatitis C Virus (HCV) and Hepatitis & HIV Coinfection the Hepatitis Report July 9-14, 2000
News on the Fight to End Hiv/Aids, Hepatitis C, and Tuberculosis
Full PDF of Tagline Spring 2018
Regime Change in America: Tracking Tag’S Work Across Eight National Election Cycles
2020 Tuberculosis Treatment PIPELINE REPORT 2020
TAG Newsletter 5-2002
Top View
Ten Texts on Saquinavir
ACTIVIST GUIDE to HEPATITIS C VIRUS DIAGNOSTICS This Guide May Be Used with Attribution for Noncommercial Purposes
TAG at Ten 1992 to 2002
TAG 2020 Annual Report
Tuberculosis Research Funding Trends 2005-2018
Hepatitis C Virus & Coinfection With
An Activist's Guide to Treatment for Drug
The Ascent Begins
BRINGING DOWN the HOUSE on INTELLECTUAL PROPERTY and ACCESS Tagline Vol
Public Health Partnership Launched to Tackle Silent Epidemic of Hepatitis C
Treatment Action Group Testimony to United States Senate
Dr-Tb & Tb-Prevention Drugs Under the Microscope
Overcoming the Barriers to an Hcv-Free Future
Full PDF of November 2019 Tagline
TAG Update 2003
COVID-19 and Impacted Communities: a Media Communications Guide
For Increasing Access to HCV Treatment in Low- and Middle-Income Countries
Tracy Swan Hepatitis/HIV Project, Treatment Action Group New York, USA